SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A.Y. Sokolov, O.A. Lyubashina, R.R. Berkovich, S.S. Panteleev, Intravenous dextromethorphan/quinidine inhibits activity of dura-sensitive spinal trigeminal neurons in rats, European Journal of Pain, 2015, 19, 2
  2. 2
    Stephen D Silberstein, Jessica C Stirpe, COX inhibitors for the treatment of migraine, Expert Opinion on Pharmacotherapy, 2014, 15, 13, 1863

    CrossRef

  3. 3
    Alexey Y. Sokolov, Olga A. Lyubashina, Ivan B. Sivachenko, Sergey S. Panteleev, Effects of intravenous metamizole on ongoing and evoked activity of dura-sensitive thalamic neurons in rats, European Journal of Pharmacology, 2014, 731, 58

    CrossRef

  4. 4
    Mia T. Minen, Kaloyan Tanev, Benjamin W. Friedman, Evaluation and Treatment of Migraine in the Emergency Department: A Review, Headache: The Journal of Head and Face Pain, 2014, 54, 7
  5. You have free access to this content5
    S E Erdener, T Dalkara, Modelling headache and migraine and its pharmacological manipulation, British Journal of Pharmacology, 2014, 171, 20
  6. 6
    Morris Levin, Opioids in Headache, Headache: The Journal of Head and Face Pain, 2014, 54, 1
  7. 7
    Roshni Ramachandran, Tony L Yaksh, Therapeutic use of botulinum toxin in migraine: mechanisms of action, British Journal of Pharmacology, 2014, 171, 18
  8. 8
    P.J. Goadsby, E. Cittadini, Encyclopedia of the Neurological Sciences, 2014,

    CrossRef

  9. 9
    Simon Akerman, Marcela Romero-Reyes, Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine, Expert Review of Neurotherapeutics, 2013, 13, 9, 1041

    CrossRef

  10. 10
    Oliver Summ, Stefan Evers, Mechanism of Action of Indomethacin in Indomethacin-Responsive Headaches, Current Pain and Headache Reports, 2013, 17, 4

    CrossRef

  11. 11
    Joel R. Saper, Arnaldo Neves Da Silva, Medication Overuse Headache: History, Features, Prevention and Management Strategies, CNS Drugs, 2013, 27, 11, 867

    CrossRef

  12. 12
    Irene Worthington, Tamara Pringsheim, Marek J. Gawel, Jonathan Gladstone, Paul Cooper, Esma Dilli, Michel Aube, Elizabeth Leroux, Werner J. Becker, Pharmacological Acute Migraine Treatment Strategies: Choosing the Right Drug for a Specific Patient, The Canadian Journal of Neurological Sciences, 2013, 40, S3, s33

    CrossRef

  13. 13
    Tailor treatment choice for acute migraine to attack severity and impact, Drugs & Therapy Perspectives, 2013, 29, 2, 45

    CrossRef

  14. 14
    Arnaldo N. Da Silva, Stewart J. Tepper, Acute Treatment of Migraines, CNS Drugs, 2012, 26, 10, 823

    CrossRef

  15. 15
    Paola Sarchielli, Franco Granella, Maria Pia Prudenzano, Luigi Alberto Pini, Vincenzo Guidetti, Giorgio Bono, Lorenzo Pinessi, Massimo Alessandri, Fabio Antonaci, Marcello Fanciullacci, Anna Ferrari, Mario Guazzelli, Giuseppe Nappi, Grazia Sances, Giorgio Sandrini, Lidia Savi, Cristina Tassorelli, Giorgio Zanchin, Italian guidelines for primary headaches: 2012 revised version, The Journal of Headache and Pain, 2012, 13, S2, 31

    CrossRef

  16. 16
    Piet Borgdorff, Geert Jan Tangelder, Migraine: Possible Role of Shear-Induced Platelet Aggregation With Serotonin Release, Headache: The Journal of Head and Face Pain, 2012, 52, 8
  17. 17
    Stewart J. Tepper, Opioids Should Not Be Used in Migraine, Headache: The Journal of Head and Face Pain, 2012, 52,
  18. 18
    Andrew Blumenfeld, Chris Gennings, Roger Cady, Pharmacological Synergy: The Next Frontier on Therapeutic Advancement for Migraine, Headache: The Journal of Head and Face Pain, 2012, 52, 4
  19. 19
    Nancy E. Kelley, Deborah E. Tepper, Rescue Therapy for Acute Migraine, Part 1: Triptans, Dihydroergotamine, and Magnesium, Headache: The Journal of Head and Face Pain, 2012, 52, 1
  20. You have free access to this content20
    Nancy E. Kelley, Deborah E. Tepper, Rescue Therapy for Acute Migraine, Part 3: Opioids, NSAIDs, Steroids, and Post-Discharge Medications, Headache: The Journal of Head and Face Pain, 2012, 52, 3
  21. 21
    Carolyn Bernstein, Rami Burstein, Sensitization of the Trigeminovascular Pathway: Perspective and Implications to Migraine Pathophysiology, Journal of Clinical Neurology, 2012, 8, 2, 89

    CrossRef

  22. 22
    Alexey Y. Sokolov, Olga A. Lyubashina, Sergey S. Panteleev, Spinal trigeminal neurons demonstrate an increase in responses to dural electrical stimulation in the orofacial formalin test, The Journal of Headache and Pain, 2012, 13, 1, 75

    CrossRef

  23. 23
    Stephen Landy, Rebecca Hoagland, Nancy A. Hoagland, Sumatriptan–Naproxen Migraine Efficacy in Allodynic Patients: Early Intervention, Headache: The Journal of Head and Face Pain, 2012, 52, 1
  24. 24
    O.A. Lyubashina, A.Y. Sokolov, S.S. Panteleev, Vagal afferent modulation of spinal trigeminal neuronal responses to dural electrical stimulation in rats, Neuroscience, 2012, 222, 29

    CrossRef

  25. 25
    Edwin Choon Wyn Lim, Michele Sterling, Andrew Stone, Bill Vicenzino, Central hyperexcitability as measured with nociceptive flexor reflex threshold in chronic musculoskeletal pain: A systematic review, Pain, 2011, 152, 8, 1811

    CrossRef

  26. 26
    John F. Rothrock, Commentary, Headache: The Journal of Head and Face Pain, 2011, 51, 4
  27. 27
    Sheridan M. Hoy, Lesley J. Scott, Indomethacin/Prochlorperazine/Caffeine, CNS Drugs, 2011, 25, 4, 343

    CrossRef

  28. 28
    Nasim Maleki, Lino Becerra, Lauren Nutile, Gautam Pendse, Jennifer Brawn, Marcelo Bigal, Rami Burstein, David Borsook, Migraine attacks the Basal Ganglia, Molecular Pain, 2011, 7, 1, 71

    CrossRef

  29. You have free access to this content29
    Peer C. Tfelt-Hansen, Peter J. Koehler, One Hundred Years of Migraine Research: Major Clinical and Scientific Observations From 1910 to 2010, Headache: The Journal of Head and Face Pain, 2011, 51, 5
  30. 30
    Frederick R. Taylor, Robert G. Kaniecki, Symptomatic Treatment of Migraine: When to Use NSAIDs, Triptans, or Opiates, Current Treatment Options in Neurology, 2011, 13, 1, 15

    CrossRef

  31. 31
    Marcelo E. Bigal, Tolerance to Headache Medications, Headache: The Journal of Head and Face Pain, 2011, 51, 8
  32. 32
    Elisabetta Cittadini, Peter J. Goadsby, Update on Hemicrania Continua, Current Pain and Headache Reports, 2011, 15, 1, 51

    CrossRef

  33. 33
    Julie Wieseler, Amanda Ellis, David Sprunger, Kim Brown, Andrew McFadden, John Mahoney, Niloofar Rezvani, Steven F. Maier, Linda R. Watkins, A novel method for modeling facial allodynia associated with migraine in awake and freely moving rats, Journal of Neuroscience Methods, 2010, 185, 2, 236

    CrossRef

  34. 34
    Joel R. Saper, Alvin E. Lake, Philip A. Bain, Mark J. Stillman, John F. Rothrock, Ninan T. Mathew, Robert L. Hamel, Maureen Moriarty, Gretchen E. Tietjen, A Practice Guide for Continuous Opioid Therapy for Refractory Daily Headache: Patient Selection, Physician Requirements, and Treatment Monitoring, Headache: The Journal of Head and Face Pain, 2010, 50, 7
  35. 35
    Anna P Andreou, Oliver Summ, Annabelle R Charbit, Marcela Romero-Reyes, Peter J Goadsby, Animal models of headache: from bedside to bench and back to bedside, Expert Review of Neurotherapeutics, 2010, 10, 3, 389

    CrossRef

  36. 36
    Anders Hougaard, Peer Tfelt-Hansen, Are the current IHS guidelines for migraine drug trials being followed?, The Journal of Headache and Pain, 2010, 11, 6, 457

    CrossRef

  37. 37
    Wen-han Hu, Kai Zhang, Jian-guo Zhang, Atypical trigeminal neuralgia: A consequence of central sensitization?, Medical Hypotheses, 2010, 75, 1, 65

    CrossRef

  38. 38
    Andrew D Hershey, Current approaches to the diagnosis and management of paediatric migraine, The Lancet Neurology, 2010, 9, 2, 190

    CrossRef

  39. 39
    Chad Whyte, Stewart J Tepper, Randolph W. Evans, Expert Opinion: Rescue Me: Rescue Medication for Migraine, Headache: The Journal of Head and Face Pain, 2010, 50, 2
  40. 40
    Thomas Simopoulos, Zahid Bajwa, George Lantz, Steve Lee, Rami Burstein, Implanted Auriculotemporal Nerve Stimulator for the Treatment of Refractory Chronic Migraine, Headache: The Journal of Head and Face Pain, 2010, 50, 6
  41. 41
    Matthew S. Robbins, Richard B. Lipton, Management of Headache in the Elderly, Drugs & Aging, 2010, 27, 5, 377

    CrossRef

  42. 42
    Bo Lian, Louis Vera-Portocarrero, Tamara King, Michael H. Ossipov, Frank Porreca, Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity, Brain Research, 2010, 1358, 64

    CrossRef

  43. 43
    G. Casucci, V. Villani, F. Frediani, Remarks on an educational training course on headache, Neurological Sciences, 2010, 31, S1, 121

    CrossRef

  44. 44
    Morris Levin, Resident and Fellow Section, Headache: The Journal of Head and Face Pain, 2010, 50, 4
  45. 45
    Triptan Therapy in Migraine, New England Journal of Medicine, 2010, 363, 14, 1377

    CrossRef

  46. 46
    Rami Burstein, Moshe Jakubowski, Headache, 2010,

    CrossRef

  47. 47
    Stewart J. Tepper, Roderick C. Spears, Acute Treatment of Migraine, Neurologic Clinics, 2009, 27, 2, 417

    CrossRef

  48. 48
    William B. Young, Allodynia as a complication of migraine: Background and management, Current Treatment Options in Neurology, 2009, 11, 1, 3

    CrossRef

  49. 49
    Carlo Lovati, Domenico D’Amico, Pierluigi Bertora, Allodynia in migraine: frequent random association or unavoidable consequence?, Expert Review of Neurotherapeutics, 2009, 9, 3, 395

    CrossRef

  50. 50
    R Burstein, M Jakubowski, Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al., Cephalalgia, 2009, 29, 10
  51. You have free access to this content51
    Benjamin Friedman, Polly Bijur, Peter Greenwald, Richard Lipton, E. John Gallagher, Clinical Significance of Brush Allodynia in Emergency Patients With Migraine, Headache: The Journal of Head and Face Pain, 2009, 49, 1
  52. 52
    Benjamin Wolkin Friedman, Brian Mitchell Grosberg, Diagnosis and Management of the Primary Headache Disorders in the Emergency Department Setting, Emergency Medicine Clinics of North America, 2009, 27, 1, 71

    CrossRef

  53. 53
    Ninan T. Mathew, Stephen Landy, Stuart Stark, Gretchen E. Tietjen, Frederick J. Derosier, Jonathan White, Shelly E. Lener, Deo Bukenya, Fixed-Dose Sumatriptan and Naproxen in Poor Responders to Triptans With a Short Half-Life, Headache: The Journal of Head and Face Pain, 2009, 49, 7
  54. 54
    CJ Schankin, M Krumbholz, P Sostak, VM Reinisch, R Goldbrunner, A Straube, Headache in patients with a meningioma correlates with a bone-invasive growth pattern but not with cytokine expression, Cephalalgia, 2009, 29, 12
  55. 55
    Michael Marmura, Hemicrania Continua: Factors Predicting Response?, Headache: The Journal of Head and Face Pain, 2009, 49, 7
  56. 56
    MJ Marmura, SD Silberstein, M Gupta, Hemicrania continua: who responds to indomethacin?, Cephalalgia, 2009, 29, 3
  57. 57
    Tony W. Ho, Anthony Rodgers, Marcelo E. Bigal, Impact of Recent Prior Opioid Use on Rizatriptan Efficacy. A Post Hoc Pooled Analysis, Headache: The Journal of Head and Face Pain, 2009, 49, 3
  58. 58
    Xi-Chun Zhang, Vanessa Kainz, Moshe Jakubowski, Rami Burstein, Andrew Strassman, Dan Levy, Localization of COX-1 and COX-2 in the intracranial dura mater of the rat, Neuroscience Letters, 2009, 452, 1, 33

    CrossRef

  59. 59
    Rebecca M. Edelmayer, Todd W. Vanderah, Lisa Majuta, En-Tan Zhang, Beatriz Fioravanti, Milena De Felice, Juliana G. Chichorro, Michael H. Ossipov, Tamara King, Josephine Lai, Shashi H. Kori, Andrew C. Nelsen, Keri E. Cannon, Mary M. Heinricher, Frank Porreca, Medullary pain facilitating neurons mediate allodynia in headache-related pain, Annals of Neurology, 2009, 65, 2
  60. 60
    Carl Dahlöf, Hans-Christoph Diener, Migraine: an endemic disease inside the blood–brain barrier, Future Neurology, 2009, 4, 4, 405

    CrossRef

  61. 61
    Karl Messlinger, Migraine: where and how does the pain originate?, Experimental Brain Research, 2009, 196, 1, 179

    CrossRef

  62. 62
    Roger K. Cady, Morris Maizels, Dennis L. Reeves, Daniel M. Levinson, Judith K. Evans, Predictors of Adherence to Triptans: Factors of Sustained vs Lapsed Users, Headache: The Journal of Head and Face Pain, 2009, 49, 3
  63. 63
    T Wienecke, J Olesen, PS Oturai, M Ashina, Prostaglandin E2 (PGE2) induces headache in healthy subjects, Cephalalgia, 2009, 29, 5
  64. 64
    T Wienecke, J Olesen, M Ashina, Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs, Cephalalgia, 2009, 29, 12
  65. 65
    Michael J Marmura, Response, Cephalalgia, 2009, 29, 12
  66. 66
    Hedvig Varga, Arpad Pardutz, Eniko Vamos, Zsuzsanna Bohar, Ferenc Bago, Janos Tajti, Ferenc Bari, Laszlo Vecsei, Selective inhibition of cyclooxygenase-2 attenuates nitroglycerin-induced calmodulin-dependent protein kinase II alpha in rat trigeminal nucleus caudalis, Neuroscience Letters, 2009, 451, 2, 170

    CrossRef

  67. 67
    Carla Ghelardini, Nicoletta Galeotti, Elisa Vivoli, Irene Grazioli, Carla Uslenghi, The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model, The Journal of Headache and Pain, 2009, 10, 6, 435

    CrossRef

  68. 68
    G. A. Lambert, J. B. Davis, J. M. Appleby, B. A. Chizh, K. L. Hoskin, A. S. Zagami, The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission, Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, 380, 4, 311

    CrossRef

  69. 69
    Deborah Friedman, Steven Feldon, Robert Holloway, Susan Fisher, Utilization, Diagnosis, Treatment and Cost of Migraine Treatment in the Emergency Department, Headache: The Journal of Head and Face Pain, 2009, 49, 8
  70. 70
    Clinician’s Guide to Chronic Headache and Facial Pain, 2009,

    CrossRef

  71. 71
    Bert B Vargas, David W Dodick, 2007 Scottsdale Headache Symposium, Expert Review of Neurotherapeutics, 2008, 8, 2, 201

    CrossRef

  72. 72
    Andrew Charles, K.C. Brennan, A touch of increased pain: Cutaneous allodynia in migraine, Annals of Neurology, 2008, 63, 2
  73. 73
    J Schoenen, N De Klippel, S Giurgea, L Herroelen, J Jacquy, P Louis, G Monseu, M Vandenheede, Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia, Cephalalgia, 2008, 28, 10
  74. 74
    Joel R. Saper, Alvin E. Lake III, Continuous Opioid Therapy (COT) is Rarely Advisable for Refractory Chronic Daily Headache: Limited Efficacy, Risks, and Proposed Guidelines, Headache: The Journal of Head and Face Pain, 2008, 48, 6
  75. 75
    M. Schürks, H.-C. Diener, Migraine, allodynia, and implications for treatment, European Journal of Neurology, 2008, 15, 12
  76. 76
    M. Schürks, H.-C. Diener, Pathophysiologie der Migräne im klinischen Kontext, Der Schmerz, 2008, 22, 5, 523

    CrossRef

  77. 77
    Troels Wienecke, Jes Olesen, Peter S. Oturai, Messoud Ashina, Prostacyclin (epoprostenol) induces headache in healthy subjects, Pain, 2008, 139, 1, 106

    CrossRef

  78. 78
    Benjamin W. Friedman, Michael L. Hochberg, David Esses, Brian M. Grosberg, Daniel Rothberg, Benjamin Bernstein, Polly E. Bijur, Richard B. Lipton, E. John Gallagher, Recurrence of Primary Headache Disorders After Emergency Department Discharge: Frequency and Predictors of Poor Pain and Functional Outcomes, Annals of Emergency Medicine, 2008, 52, 6, 696

    CrossRef

  79. 79
    David W. Dodick, Reflections and Speculations on Refractory Migraine: Why Do Some Patients Fail to Improve With Currently Available Therapies?, Headache: The Journal of Head and Face Pain, 2008, 48, 6
  80. 80
    Dan Levy, Xi-Chun Zhang, Moshe Jakubowski, Rami Burstein, Sensitization of meningeal nociceptors: inhibition by naproxen, European Journal of Neuroscience, 2008, 27, 4
  81. 81
    L Edvinsson, P Tfelt-Hansen, The blood–brain barrier in migraine treatment, Cephalalgia, 2008, 28, 12
  82. 82
    John F. Rothrock, Treatment-Refractory Migraine: The Case for Opioid Therapy, Headache: The Journal of Head and Face Pain, 2008, 48, 6
  83. 83
    Lara Cooke, Michael Eliasziw, Werner J. Becker, Cutaneous Allodynia in Transformed Migraine Patients, Headache: The Journal of Head and Face Pain, 2007, 47, 4
  84. 84
    G. Sandrini, R. Cerbo, E. Del Bene, A. Ferrari, S. Genco, I. Grazioli, P. Martelletti, G. Nappi, L. Pinessi, P. Sarchielli, P. Tamburro, C. Uslenghi, G. Zanchin, Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study, International Journal of Clinical Practice, 2007, 61, 8
  85. 85
    Andrew D Hershey, Paul Winner, Marielle A Kabbouche, Scott W Powers, Headaches, Current Opinion in Pediatrics, 2007, 19, 6, 663

    CrossRef

  86. 86
    Madhavi X. Gupta, Stephen D. Silberstein, William B. Young, Mary Hopkins, Bernard L. Lopez, Gregory P. Samsa, Less Is Not More: Underutilization of Headache Medications in a University Hospital Emergency Department, Headache: The Journal of Head and Face Pain, 2007, 47, 8
  87. 87
    M. Roch, K. Messlinger, V. Kulchitsky, O. Tichonovich, O. Azev, S. Koulchitsky, Ongoing activity in trigeminal wide-dynamic range neurons is driven from the periphery, Neuroscience, 2007, 150, 3, 681

    CrossRef

  88. 88
    Peter J. Goadsby, Recent advances in understanding migraine mechanisms, molecules and therapeutics, Trends in Molecular Medicine, 2007, 13, 1, 39

    CrossRef

  89. 89
    M. Jakubowski, D. Levy, V. Kainz, X.-C. Zhang, B. Kosaras, R. Burstein, Sensitization of central trigeminovascular neurons: Blockade by intravenous naproxen infusion, Neuroscience, 2007, 148, 2, 573

    CrossRef

  90. 90
    Paola Sarchielli, Massimiliano Filippo, Katiuscia Nardi, Paolo Calabresi, Sensitization, glutamate, and the link between migraine and fibromyalgia, Current Pain and Headache Reports, 2007, 11, 5, 343

    CrossRef

  91. 91
    Stewart J. Tepper, ACUTE TREATMENT OF MIGRAINE, CONTINUUM: Lifelong Learning in Neurology, 2006, 12, 87

    CrossRef

  92. 92
    Joel R. Saper, APPROACH TO THE INTRACTABLE HEADACHE CASE, CONTINUUM: Lifelong Learning in Neurology, 2006, 12, 259

    CrossRef

  93. 93
    David Dodick, Stephen Silberstein, Central Sensitization Theory of Migraine: Clinical Implications, Headache: The Journal of Head and Face Pain, 2006, 46,
  94. 94
    Carl Dahlöf, Cutaneous allodynia and migraine: Another view, Current Pain and Headache Reports, 2006, 10, 3, 231

    CrossRef

  95. 95
    Giorgio Sandrini, Armando Perrotta, Giuseppe Nappi, Eletriptan: a review and new perspectives, Expert Review of Neurotherapeutics, 2006, 6, 10, 1413

    CrossRef

  96. 96
    Peter J Goadsby, Headache: a good year for research, The Lancet Neurology, 2006, 5, 1, 5

    CrossRef

  97. 97
    Michael L. Oshinsky, Insights from experimental studies into allodynia and its treatment, Current Pain and Headache Reports, 2006, 10, 3, 225

    CrossRef

  98. 98
    JR Saper, AE Lake, Medication overuse headache: type I and type II, Cephalalgia, 2006, 26, 10
  99. 99
    Joel R. Saper, Alvin E. Lake, Sustained Opioid Therapy Should Rarely Be Administered to Headache Patients: Clinical Observations, Literature Review, and Proposed Guidelines, Headache Currents, 2006, 3, 3
  100. 100
    Parisa Gazerani, Camilla Staahl, Asbjøn M. Drewes, Lars Arendt-Nielsen, The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization, Pain, 2006, 122, 3, 315

    CrossRef

  101. 101
    James R. Couch, The long-term prognosis of tension-type headache, Current Pain and Headache Reports, 2005, 9, 6, 436

    CrossRef

  102. 102
    Victoria L. Thornton, Lauren T. Southerland, Adults with Conditions Causing Chronic Pain,